140 related articles for article (PubMed ID: 17304172)
1. [Lafora's disease (EPM2)].
Genton P
Rev Neurol (Paris); 2007 Jan; 163(1):47-53. PubMed ID: 17304172
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy.
Ganesh S; Puri R; Singh S; Mittal S; Dubey D
J Hum Genet; 2006; 51(1):1-8. PubMed ID: 16311711
[TBL] [Abstract][Full Text] [Related]
3. [Lafora's disease presenting with progressive myoclonus epilepsy].
Béjot Y; Lemesle-Martin M; Contégal F; Graule-Petot A; Thauvin C; Aubriot-Lorton MH; Moreau T; Giroud M
Rev Neurol (Paris); 2007 Oct; 163(10):975-8. PubMed ID: 18033035
[TBL] [Abstract][Full Text] [Related]
4. Severe and rapidly-progressive Lafora disease associated with NHLRC1 mutation: a case report.
Casciato S; Gambardella S; Mascia A; Quarato PP; D'Aniello A; Ackurina Y; Albano V; Fornai F; Scala S; Di Gennaro G
Int J Neurosci; 2017 Dec; 127(12):1150-1153. PubMed ID: 28556688
[TBL] [Abstract][Full Text] [Related]
5. Lafora's disease: towards a clinical, pathologic, and molecular synthesis.
Minassian BA
Pediatr Neurol; 2001 Jul; 25(1):21-9. PubMed ID: 11483392
[TBL] [Abstract][Full Text] [Related]
6. Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy.
Ki CS; Kong SY; Seo DW; Hong SB; Kim HJ; Kim JW
J Hum Genet; 2003; 48(1):51-4. PubMed ID: 12560877
[TBL] [Abstract][Full Text] [Related]
7. The presenting symptoms of Lafora Disease: An electroclinical and genetic study in five Apulian (Southern Italy) families.
d'Orsi G; Lalla A; Palumbo O; Di Claudio MT; Valenzano A; Sabetta A; Lopopolo A; Muro ED; Palumbo P; Copetti M; Carella M; Avolio C
Seizure; 2020 Dec; 83():145-153. PubMed ID: 33152654
[TBL] [Abstract][Full Text] [Related]
8. Lafora progressive myoclonus epilepsy: recent insights into cell degeneration.
Spuch C; Ortolano S; Navarro C
Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):99-107. PubMed ID: 22369717
[TBL] [Abstract][Full Text] [Related]
9. Lafora disease.
Turnbull J; Tiberia E; Striano P; Genton P; Carpenter S; Ackerley CA; Minassian BA
Epileptic Disord; 2016 Sep; 18(S2):38-62. PubMed ID: 27702709
[TBL] [Abstract][Full Text] [Related]
10. [Myoclonic epilepsy of Lafora: a case report].
Rudenskaia GE; Zakharova EIu; Karpin SL; Uchaev DA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):11-6. PubMed ID: 20873469
[TBL] [Abstract][Full Text] [Related]
11. [Molecular genetics of epilepsy].
Yamakawa K
Rinsho Shinkeigaku; 2004 Nov; 44(11):858-60. PubMed ID: 15651314
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.
Ganesh S; Delgado-Escueta AV; Suzuki T; Francheschetti S; Riggio C; Avanzini G; Rabinowicz A; Bohlega S; Bailey J; Alonso ME; Rasmussen A; Thomson AE; Ochoa A; Prado AJ; Medina MT; Yamakawa K
Hum Mol Genet; 2002 May; 11(11):1263-71. PubMed ID: 12019207
[TBL] [Abstract][Full Text] [Related]
13. Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora.
Gómez-Garre P; Gutiérrez-Delicado E; Gómez-Abad C; Morales-Corraliza J; Villanueva VE; Rodríguez de Córdoba S; Larrauri J; Gutiérrez M; Berciano J; Serratosa JM
Neurology; 2007 Apr; 68(17):1369-73. PubMed ID: 17452581
[TBL] [Abstract][Full Text] [Related]
14. A case of Lafora's disease associated with cardiac arrhythmia.
Oksel F; Tekgül H; Genç S; Ozyürek R; Akalin T; Tütütüncüoğlu S
J Child Neurol; 1999 Nov; 14(11):745-6. PubMed ID: 10593553
[TBL] [Abstract][Full Text] [Related]
15. Lafora disease.
Madhavan D; Kuzniecky RI
Rev Neurol Dis; 2006; 3(3):131-5. PubMed ID: 17047580
[TBL] [Abstract][Full Text] [Related]
16. Lafora Disease: A Review of Molecular Mechanisms and Pathology.
Verhalen B; Arnold S; Minassian BA
Neuropediatrics; 2018 Dec; 49(6):357-362. PubMed ID: 30336494
[TBL] [Abstract][Full Text] [Related]
17. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy.
Minassian BA; Lee JR; Herbrick JA; Huizenga J; Soder S; Mungall AJ; Dunham I; Gardner R; Fong CY; Carpenter S; Jardim L; Satishchandra P; Andermann E; Snead OC; Lopes-Cendes I; Tsui LC; Delgado-Escueta AV; Rouleau GA; Scherer SW
Nat Genet; 1998 Oct; 20(2):171-4. PubMed ID: 9771710
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of zonisamide in Lafora's disease case and brief review of its use in progressive myoclonic epilepsy].
Rubio-Nazábal E; Álvarez-Pérez P; Cores-Bartolomé C; Lema-Facal T
Rev Neurol; 2022 Sep; 75(6):159-163. PubMed ID: 36098450
[TBL] [Abstract][Full Text] [Related]
19. [Progressive myoclonic epilepsy type Lafora].
Chemaly R; Checrallah A; Trak-Smayra V; El-Kallab K; Chemaly E
J Med Liban; 2001; 49(3):170-2. PubMed ID: 12187920
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
